Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Exact Sciences Cor (EXAS)
Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,154,150
  • Shares Outstanding, K 180,475
  • Annual Sales, $ 2,084 M
  • Annual Income, $ -623,510 K
  • 60-Month Beta 1.39
  • Price/Sales 7.77
  • Price/Cash Flow N/A
  • Price/Book 5.55
Trade EXAS with:

Options Overview Details

View History
  • Implied Volatility 41.08% ( -0.81%)
  • Historical Volatility 36.10%
  • IV Percentile 0%
  • IV Rank 1.67%
  • IV High 128.30% on 11/28/22
  • IV Low 39.59% on 06/21/23
  • Put/Call Vol Ratio 1.67
  • Today's Volume 2,030
  • Volume Avg (30-Day) 2,003
  • Put/Call OI Ratio 0.82
  • Today's Open Interest 49,951
  • Open Int (30-Day) 46,423

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.53
  • Number of Estimates 8
  • High Estimate -0.38
  • Low Estimate -0.65
  • Prior Year -0.94
  • Growth Rate Est. (year over year) +43.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.69 +16.23%
on 05/31/23
99.00 -6.45%
on 06/21/23
+10.62 (+12.95%)
since 05/23/23
3-Month
61.31 +51.07%
on 05/01/23
99.00 -6.45%
on 06/21/23
+27.21 (+41.60%)
since 03/23/23
52-Week
29.27 +216.43%
on 10/13/22
99.00 -6.45%
on 06/21/23
+50.38 (+119.27%)
since 06/23/22

Most Recent Stories

More News
2 Stocks to Invest $500 In and Hold For 10 Years

Both companies have outperformed the market over the past year.

EXAS : 92.62 (-2.56%)
PINS : 26.24 (+0.38%)
Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced separate collaborations with...

EXAS : 92.62 (-2.56%)
S&P Futures Tick Lower Ahead of Powell Testimony

September S&P 500 futures (ESU23) are trending down -0.06% this morning after three major U.S. benchmark indices finished the regular session lower as market participants weighed China’s outlook while...

ESU23 : 4,389.00s (-0.79%)
JD : 34.87 (-4.70%)
PDD : 69.80 (-4.24%)
NKE : 109.52 (-0.85%)
TSLA : 256.60 (-3.03%)
PYPL : 66.94 (-2.38%)
HFD.LN : 212.000 (-1.58%)
FDX : 232.34 (-0.25%)
PTON : 7.31 (-2.86%)
PCT : 9.25 (-5.80%)
EXAS : 92.62 (-2.56%)
ABR : 13.65 (-3.05%)
Next-generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent Specificity, Raising the Bar in Non-invasive Screening

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced positive top-line results...

EXAS : 92.62 (-2.56%)
1 Unstoppable Growth Stock to Buy and Hold for 10 Years

This company is finding success in fighting one of the deadliest illnesses.

EXAS : 92.62 (-2.56%)
Exact Sciences to participate in June investor conferences

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will...

EXAS : 92.62 (-2.56%)
Exact Sciences Presents New Long-Term Patient Outcomes in Multi-Cancer Early Detection and Breast Cancer Recurrence Testing at ASCO® 2023

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today that it will present 15...

EXAS : 92.62 (-2.56%)
3 High-Flying Cathie Wood Stocks That Are Up Over 50% This Year

Is it too late to buy these rebounding stocks?

TSLA : 256.60 (-3.03%)
DKNG : 25.03 (-1.80%)
EXAS : 92.62 (-2.56%)
These 3 Stocks Have Had at Least 4 Quarters of Earnings Surprises.

Earning season is about to end. What stocks can investors look at now?

EXAS : 92.62 (-2.56%)
RLJ : 9.75 (-1.81%)
PL : 3.07 (-2.85%)
Markets Today: Stocks Climb as Sentiment Improves for a Debt Ceiling Deal

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are up +0.31% at a 9-month nearest-futures high, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.05% at a 13-month high. U.S. stock...

ESU23 : 4,389.00s (-0.79%)
NQU23 : 15,058.25s (-1.03%)
DE : 404.45 (-2.70%)
PLTR : 14.03 (-0.14%)
FTCH : 5.35 (-3.25%)
BE : 15.44 (-4.87%)
GLOB : 174.75 (-2.51%)
PACW : 7.23 (+0.56%)
CTLT : 44.06 (-0.34%)
FL : 25.93 (-2.08%)
AMAT : 136.07 (-2.05%)
EXAS : 92.62 (-2.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has developed an accurate, non-invasive, patient-friendly screening test called Cologuard for the early detection of colorectal cancer and...

See More

Key Turning Points

3rd Resistance Point 97.58
2nd Resistance Point 95.84
1st Resistance Point 94.23
Last Price 92.62
1st Support Level 90.88
2nd Support Level 89.14
3rd Support Level 87.53

See More

52-Week High 99.00
Last Price 92.62
Fibonacci 61.8% 72.37
Fibonacci 50% 64.14
Fibonacci 38.2% 55.91
52-Week Low 29.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar